John Pratt

Insider

First SEC filing: March 14, 2013 · Latest: March 14, 2013

On this page

Insider at Companies where this person is a reporting insider.
Insider transactions Every share this person bought or sold, from Form 4 filings.
Derivatives Options and other derivative holdings reported by this person.

Insider at

PCRX selling June 13, 2013

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 14 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

14 other filings hidden

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
June 13, 2013	PCRX	M	1,875	—	—	18,750 Direct	-9.09%	Disposed	(price as of 2026-08-19)
June 13, 2013	PCRX	M	18,232	—	—	112,500 Direct	-13.95%	Disposed	(price as of 2026-08-19)
June 13, 2013	PCRX	S	1,875	$30.00	$56,250	0 Direct	-100.00%	Disposed	-18.3% (price as of 2026-08-19)
June 13, 2013	PCRX	M	1,875	$8.73	$16,369	1,875 Direct	—	Acquired	180.9% (price as of 2026-08-19)
June 13, 2013	PCRX	S	18,232	$30.00	$546,960	0 Direct	-100.00%	Disposed	-18.3% (price as of 2026-08-19)
June 13, 2013	PCRX	M	18,232	$10.81	$197,088	18,232 Direct	—	Acquired	126.8% (price as of 2026-08-19)
June 12, 2013	PCRX	M	925	—	—	130,732 Direct	-0.70%	Disposed	(price as of 2026-08-19)
June 12, 2013	PCRX	S	925	$30.00	$27,750	0 Direct	-100.00%	Disposed	-18.3% (price as of 2026-08-19)
June 12, 2013	PCRX	M	925	$10.81	$9,999	925 Direct	—	Acquired	126.8% (price as of 2026-08-19)
June 11, 2013	PCRX	M	12,945	—	—	131,657 Direct	-8.95%	Disposed	(price as of 2026-08-19)
June 11, 2013	PCRX	S	12,945	$30.00	$388,350	0 Direct	-100.00%	Disposed	-18.3% (price as of 2026-08-19)
June 11, 2013	PCRX	M	12,945	$10.81	$139,935	12,945 Direct	—	Acquired	126.8% (price as of 2026-08-19)
June 10, 2013	PCRX	M	5,398	—	—	144,602 Direct	-3.60%	Disposed	(price as of 2026-08-19)
June 10, 2013	PCRX	S	5,398	$30.00	$161,940	0 Direct	-100.00%	Disposed	-18.3% (price as of 2026-08-19)
June 10, 2013	PCRX	M	5,398	$10.81	$58,352	5,398 Direct	—	Acquired	126.8% (price as of 2026-08-19)
March 12, 2013	PCRX	M	9,375	—	—	20,625 Direct	-31.25%	Disposed	(price as of 2026-08-19)
March 12, 2013	PCRX	S	9,375	$28.46	$266,812	0 Direct	-100.00%	Disposed	-13.8% (price as of 2026-08-19)
March 12, 2013	PCRX	M	9,375	$8.73	$81,844	9,375 Direct	—	Acquired	180.9% (price as of 2026-08-19)
June 5, 2012	PCRX	A	150,000	—	—	150,000 Direct	—	Acquired	(price as of 2026-08-19)
Jan. 3, 2012	PCRX	A	30,000	—	—	30,000 Direct	—	Acquired	(price as of 2026-08-19)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
June 13, 2013	PCRX	Employee Stock Option (right to buy)	Common Stock (1,875)	$8.73	Jan. 2, 2022	1,875	Disposed
June 13, 2013	PCRX	Employee Stock Option (right to buy)	Common Stock (18,232)	$10.81	June 4, 2022	18,232	Disposed
June 12, 2013	PCRX	Employee Stock Option (right to buy)	Common Stock (925)	$10.81	June 4, 2022	925	Disposed
June 11, 2013	PCRX	Employee Stock Option (right to buy)	Common Stock (12,945)	$10.81	June 4, 2022	12,945	Disposed
June 10, 2013	PCRX	Employee Stock Option (right to buy)	Common Stock (5,398)	$10.81	June 4, 2022	5,398	Disposed
March 12, 2013	PCRX	Employee Stock Option (right to buy)	Common Stock (9,375)	$8.73	Jan. 2, 2022	9,375	Disposed
June 5, 2012	PCRX	Common Stock	Common Stock (150,000)	$10.81	June 4, 2022	150,000	Acquired
Jan. 3, 2012	PCRX	Employee Stock Option (right to buy)	Common Stock (30,000)	$8.73	Jan. 2, 2022	30,000	Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).